Micah Zajic
2023 - Lexeo Therapeutics
In 2023, Micah Zajic earned a total compensation of $3.1M as Former Chief Financial Officer at Lexeo Therapeutics.
Compensation breakdown
| Bonus | $166,000 |
|---|---|
| Option Awards | $2,464,231 |
| Salary | $423,229 |
| Other | $11,096 |
| Total | $3,064,556 |
Zajic received $2.5M in option awards, accounting for 80% of the total pay in 2023.
Zajic also received $166K in bonus, $423.2K in salary and $11.1K in other compensation.
Rankings
In 2023, Micah Zajic's compensation ranked 293rd out of 2,978 executives tracked by ExecPay. In other words, Zajic earned more than 90.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 293 out of 2,978 | 90th |
Division Manufacturing | 159 out of 1,637 | 90th |
Major group Chemicals And Allied Products | 106 out of 906 | 88th |
Industry group Drugs | 103 out of 869 | 88th |
Industry Biological Products, Except Diagnostic Substances | 36 out of 211 | 83rd |
Source: SEC filing on April 26, 2024.
Zajic's colleagues
We found three more compensation records of executives who worked with Micah Zajic at Lexeo Therapeutics in 2023.